Spero Therapeutics


Spero Therapeutics (Nasdaq: SPRO) is a multi-asset pre-commercial stage biopharmaceutical company in Cambridge, Mass. We are highly committed to advancing novel treatment approaches for bacterial infections with a world-class team of biotechnological and biopharmaceutical experts. The company has a... Read more

Industries

Employees

51-200

Links


Org chart

Sath Shukla
President & CEO
Collapse
Esther Rajavelu
CFO & Chief Business Officer
Timothy Keutzer
Chief Operating Officer, Spero Therapeutics
Thomas Parr
Chief Scientific Officer
Akash Jain
Vice President, Alliance Management And Business Development
Angela Talley
Senior Vice President, Clinical Development
Jay Blackington
VP, People Strategy & Culture
Maegan Deare
Vice President, Head Of Legal

Board & advisors

Milind Deshpande
Co-founder And Board Member
Cynthia Smith
Member Board Of Directors
Patrick Vink
Director